The Percutaneous Transmural Arterial Bypass -1 Study (Post Approval Registry)

The purpose of this post-market surveillance study will be to evaluate the real-world use of the DETOUR System in treated patients with symptomatic femoropopliteal lesions from 200 mm to 460 mm in length with chronic total occlusions (100 mm to 425 mm) or diffuse stenosis \> 70% who may be considered suboptimal candidates for surgical or alternative endovascular treatments.

NCT Number	NCT06315023
Lead Sponsor	Endologix Collaborators: Fivos, Massachusetts General Hospital, Society for Vascular Surgery Patient Safety Organization
Conditions	Peripheral Arterial Disease, Symptomatic Femoropopliteal Lesions
Enrollment	450 participants
Start Date	2023-10-06
Primary Completion	2028-06-07 (estimated)
Study Completion	2032-06-07 (estimated)
Updated on ClinicalTrials.gov	2026-05-12